OCULAR THERAPEUTIX INC's ticker is OCUL and the CUSIP is 67576A100. A total of 150 filers reported holding OCULAR THERAPEUTIX INC in Q2 2021. The put-call ratio across all filers is 0.38 and the average weighting 0.9%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q4 2021 | $150,000 | -63.8% | 21,470 | -48.2% | 0.09% | -65.2% |
| Q3 2021 | $414,000 | -7.6% | 41,420 | +31.1% | 0.26% | -5.9% |
| Q2 2021 | $448,000 | +17.9% | 31,590 | +36.4% | 0.27% | +0.7% |
| Q1 2021 | $380,000 | +35.7% | 23,160 | +71.2% | 0.27% | +1.9% |
| Q4 2020 | $280,000 | +101.4% | 13,525 | -25.7% | 0.26% | +82.8% |
| Q3 2020 | $139,000 | -3.5% | 18,200 | +5.2% | 0.14% | -0.7% |
| Q2 2020 | $144,000 | – | 17,300 | – | 0.15% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| SV Health Investors, LLC | 1,932,607 | $40,643,000 | 15.56% |
| Lamond Capital Partners LLC | 711,533 | $14,964,000 | 15.19% |
| Polaris Venture Management Co. V, L.L.C. | 1,230,009 | $25,867,000 | 11.54% |
| NOTTINGHAM ADVISORS, INC. | 171,985 | $3,617,000 | 0.60% |
| Portolan Capital Management | 122,518 | $2,577,000 | 0.36% |
| SPHERA FUNDS MANAGEMENT LTD. | 160,000 | $3,365,000 | 0.33% |
| Rotella Capital Management, Inc. | 18,461 | $388,000 | 0.32% |
| Monashee Investment Management LLC | 28,834 | $606,000 | 0.29% |
| DRIEHAUS CAPITAL MANAGEMENT LLC | 335,498 | $7,056,000 | 0.24% |
| BAILARD, INC. | 55,000 | $1,157,000 | 0.18% |